Oxycodone with naloxone - Pain
You are here : Home > Formulary Search > Oxycodone with naloxone - Pain
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Non Formulary
Formulations :
- Not Specified
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
Guidelines (National)
PAD Profile
ChemicalSubstance :
Oxycodone with naloxone
Indication :
Pain
Group Name :
Keywords :
opioids, severe pain, idiopathic restless legs syndrome' low value medicines, drugs of low clinical value, LVM, drugs of limited clinical value, PNMP, persistent non-malignant pain
Brand Names Include :
Targinact, Myloxifin
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4
Other Indications
Below are listed other indications that Oxycodone with naloxone is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Pain .
- Alfentanil hydrochloride
- Aspirin
- Buprenorphine
- Cannabis (medicinal)
- Co-codamol
- Co-dydramol 10/500
- Co-dydramol 20/500
- Co-dydramol 30/500
- Co-proxamol (Dextropropoxyphene hydrochloride/para
- Codeine phosphate
- Diamorphine hydrochloride
- Dihydrocodeine tartrate
- Fentanyl
- Gabapentin
- Ibuprofen
- Ketamine
- Meptazinol hydrochloride
- Methoxyflurane
- Morphine sulfate
- Nefopam hydrochloride
- Oxycodone
- Paracetamol
- Pethidine hydrochloride
- Pregabalin
- Sufentanil
- Tramadol hydrochloride
- Tramadol with Dexketoprofen
- Tramadol with paracetamol
- Ziconotide acetate
Committee Recommendations (1)
The Prescribing Clinical Network does not recommend the use of oxycodone and naloxone combination product
Oxycodone and Naloxone Combination Product will be considered BLACK on the traffic light system, prescribers should:
o NOT initiate oxycodone and naloxone combination product for any new patient
AND
o De-prescribe oxycodone and naloxone combination product, with specialist support if appropriate, in all patients
In exceptional circumstances where there is a clinical need for oxycodone and naloxone combination product to be prescribed in primary care this should be undertaken in a cooperation arrangement with a multidisciplinary team and / or other healthcare professional
Oxycodone and Naloxone Combination Product will be considered BLACK on the traffic light system, prescribers should:
o NOT initiate oxycodone and naloxone combination product for any new patient
AND
o De-prescribe oxycodone and naloxone combination product, with specialist support if appropriate, in all patients
In exceptional circumstances where there is a clinical need for oxycodone and naloxone combination product to be prescribed in primary care this should be undertaken in a cooperation arrangement with a multidisciplinary team and / or other healthcare professional